Belanger-Quintana A, Venegas Moreno EM, Martínez Z, de las Heras J, Campistol J, Quijada-Fraile P, Morales-Conejo M, Moreno Lozano PJ, Correcher Medina P, Sánchez-Pintos P, Hermida A, Márquez AM, González-Lamuño D, Riancho JA, Blasco-Alonso J, de la Mano A, Ruiz Pons M, Pons Rodriguez M, Peña-Quintana L, Yébenes Cortés M, Gómez-Barrera M, Fernández-Cortés F, Vallribera M, Beitia Ortiz de Zárate I, Gil D. CLARIPHY-SP Study Group
Metabolic Control and Dietary Burden in Spanish Patients with Phenylketonuria: Results from the CLARIPHY SP Study
40th European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria (E.S.PKU) Conference 2026. Demark. 22-25 oct 2026
POSTER
Belanger-Quintana A, Venegas Moreno EM, Martínez Z, de las Heras J, Campistol J, Quijada-Fraile P, Morales-Conejo M, Moreno Lozano PJ, Correcher Medina P, Sánchez-Pintos P, Hermida A, Márquez AM, González-Lamuño D, Riancho JA, Blasco-Alonso J, de la Mano A, Ruiz Pons M, Pons Rodriguez M, Peña-Quintana L, Yébenes Cortés M, Casado MA, Fernández-Cortés F, Vallribera M, Beitia Ortiz de Zárate I, and Gil D, CLARIPHY-SP Study Group
Educational Burden Associated with Poor Metabolic Control in Spanish Patients with PKU: Findings from the CLARIPHY SP Study
40th European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria (E.S.PKU) Conference 2026. Demark. 22-25 oct 2026
POSTER
Belanger-Quintana A, Venegas Moreno EM, Martínez Z, de las Heras J, Campistol J, Quijada-Fraile P, Morales-Conejo M, Moreno Lozano PJ, Correcher Medina P, Sánchez-Pintos P, Hermida A, Márquez AM, González-Lamuño D, Riancho JA, Blasco-Alonso J, de la Mano A, Ruiz Pons M, Pons Rodriguez M, Peña-Quintana L, Gómez-Barrera M, Casado MA, Fernández-Cortés F, Vallribera M, Beitia Ortiz de Zárate I, Gil D, CLARIPHY-SP Study Group
Comorbidity Burden According to Metabolic Control in Spanish Patients with PKU: Findings from the CLARIPHY SP Study
40th European Society for Phenylketonuria and Allied Disorders Treated as Phenylketonuria (E.S.PKU) Conference 2026. Demark. 22-25 oct 2026
POSTER
Meca-Lallana JE, González-Suárez I, Eichau S, Otero-Romero S, Engroba C, Yébenes M, Oreja-Guevara C
Disease Activity, Progression and Treatment Patterns Across MS Phenotypes: Real World Evidence: APOLO Study
10th Joint ACTRIMS-ECTRIMS Meeting. Toronto. 21-23 octu 2026
POSTER
Buti M, Calleja JL, Rodríguez MA, Domínguez-Hernández R, Espinoza-Cámac N, Martín-Escudero V, Cantero H
Clinical and economic value of early treatment with bulevirtide in chronic hepatitis delta virus
5th Edition of the Delta Cure International Meeting. Milan 15-16 oct 2026
POSTER
Soriano-Arandes A, Prats C, Antón A, Robles-Plaza M, de Pedro S, Oyagüez I, Capel Sanchez M, Rubín A, Sánchez G
Análisis coste-efectividad de la vacunación antigripal con la vacuna viva atenuada en niños de 2 a 11 años en Cataluña
XIII Congreso de la Asociación Española de Vacunología. Vigo. 14-17 oct 2026
POSTER